• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOLTON MEDICAL, INC. RELAY PRO NBS THORACIC STENT-GRAFT SYSTEM; STENT, ENDOVASCULAR GRAFT, AORTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOLTON MEDICAL, INC. RELAY PRO NBS THORACIC STENT-GRAFT SYSTEM; STENT, ENDOVASCULAR GRAFT, AORTIC Back to Search Results
Catalog Number 28-N4-40-204-40U
Medical Device Problem Codes Failure to Seal (4070); Device Endoleak (4074)
Health Effect - Clinical Code Clinical Endoleak (4843)
Date of Event 03/18/2025
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Bolton medical, inc.(d/b/a terumo aortic), herein known as the "company", is submitting this report pursuant to 21 cfr part 803, has made reasonable efforts to obtain complete information, and has provided as much as is available to the company as of the submission date of this report.This report is based on information obtained by the company, which may not have been able to fully investigate or verify prior to the date the report was required by the regulations.Any required fields that are unpopulated are blank because the information is currently unknown, unavailable, or not applicable.This report does not constitute an admission or a conclusion by anyone that the device caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the certain regulations, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Event or Problem Description
"endoleak (type ia): the relay pro stent graft was planned to be placed over half of the lsa against a steep arch.As the delivery system passed through the arch, the delivery system took a shortcut, advancing the inner side of the arch, resulting in insufficient deployment and creating space on the outer side of the arch.The location of the stent graft on the outer side of the arch was migrated and a type 1a endoleak occurred on final angiography.Since a relay pro stent graft (28-n4-38-199-38u) had already been implanted peripherally, there was nothing more than that could be done, and the procedure was completed.Further intervention will be considered at a later date while the patient is monitored.Operation type: stent graft implantation.No blood loss.Ancillary device used: 28-n4-38-199-38u.No image available due to hospital policy.Pre-case plan available.Additional information will be obtained.(tc#(b)(4))".Patient outcome: "the patient is under observation.".
 
Event or Problem Description
"endoleak (type ia): the relay pro stent graft was planned to be placed over half of the lsa against a steep arch.As the delivery system passed through the arch, the delivery system took a shortcut, advancing the inner side of the arch, resulting in insufficient deployment and creating space on the outer side of the arch.The location of the stent graft on the outer side of the arch was migrated and a type 1a endoleak occurred on final angiography.Since a relay pro stent graft (28-n4-38-199-38u) had already been implanted peripherally, there was nothing more than that could be done, and the procedure was completed.Further intervention will be considered at a later date while the patient is monitored.Operation type: stent graft implantation.No blood loss.Ancillary device used: 28-n4-38-199-38u.No image available due to hospital policy.Pre-case plan available.Additional information will be obtained.(tc#(b)(4))".Patient outcome: "the patient is under observation.".
 
Additional Manufacturer Narrative
Bolton medical, inc.(d/b/a terumo aortic), herein known as the "company", is submitting this report pursuant to 21 cfr part 803, has made reasonable efforts to obtain complete information, and has provided as much as is available to the company as of the submission date of this report.This report is based on information obtained by the company, which may not have been able to fully investigate or verify prior to the date the report was required by the regulations.Any required fields that are unpopulated are blank because the information is currently unknown, unavailable, or not applicable.This report does not constitute an admission or a conclusion by anyone that the device caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the certain regulations, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RELAY PRO NBS THORACIC STENT-GRAFT SYSTEM
Common Device Name
STENT, ENDOVASCULAR GRAFT, AORTIC
Manufacturer (Section D)
BOLTON MEDICAL, INC.
799 international parkway
sunrise FL 33325
Manufacturer Contact
matthew cleary
799 international parkway
sunrise, FL 33325
9548389699
MDR Report Key21835233
Report Number2247858-2025-00096
Device Sequence Number17215623
Product Code MIH
UDI-Device Identifier00843576150768
UDI-Public00843576150768
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
P200045
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2025
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Company Representative
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 04/24/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Expiration Date12/14/2025
Device Catalogue Number28-N4-40-204-40U
Device Lot Number2311300375
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 03/18/2025
Supplement Date Received by Manufacturer03/18/2025
Initial Report FDA Received Date04/14/2025
Supplement Report FDA Received Date04/24/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured12/15/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient Age74 YR
Patient SexMale
-
-